Clinical Trials Logo

Filter by:
NCT ID: NCT06444516 Not yet recruiting - Dry Eye Disease Clinical Trials

Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease

Start date: August 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate and demonstrate the efficacy and safety of an investigational ocular lubricant formulation in patients with mild to moderate dry eye disease (DED).

NCT ID: NCT06444464 Not yet recruiting - Clinical trials for Overweight and Obesity

The BEE-Power Study (Boosting Exercise for Excellent Pediatric Blood Pressure)

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to compare two types of exercises, isometric exercise (like squats and planks) and aerobic exercise (such as running), to see which one is more effective at improving blood pressure in teenagers aged 13 to 17.5 years. The main question the study aims to answer is: - Do the effects of one session of isometric exercise on the blood pressure of adolescents compare to the effects of one session of aerobic exercise? Adolescents diagnosed with high blood pressure may qualify for this study. Participants will be randomly assigned to either a single session of isometric exercise or a single session of aerobic exercise. - Participants will attend 3 study visits in total. - Study visits should be completed within 4 weeks of enrollment. - At the initial visit, samples (example: blood) will be collected and body measurements will be taken. - Participants will be asked to answer questionnaires (diet, growth, and others) - At visit 2, participants will have their blood pressure measured using a 24 hour blood pressure monitor. - At visit 3, participants will participate in a single session of either aerobic or isometric exercise. They will wear a 24-hour blood pressure monitor immediately after the exercise session.

NCT ID: NCT06444412 Not yet recruiting - WHO Grade 3 Glioma Clinical Trials

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

Start date: August 1, 2024
Phase: Phase 2
Study type: Interventional

This clinical trial evaluates whether gallium-68 (Ga-68) prostate specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed tomography (CT) imaging is useful in differentiating between disease that has come back after a period of improvement (recurrence) or that is growing, spreading, or getting worse (progression) and treatment effect in patients with glioma. Patients with glioma undergo frequent imaging for assessment of disease status. After first-line treatment however, the correlation between imaging findings and tumor activity can be confused, and surgery is often required for definitive diagnosis. The PET/CT scanner is an imaging machine that combines 2 types of imaging in a single scan. The PET scanner detects and takes pictures of where the radioactive imaging agent (68Ga PSMA-11) has gone in the body and the CT scanner uses x-rays to take structural pictures inside the body. PSMA PET also binds to neoplastic blood vessels, including those in gliomas. This study may help researchers learn whether GA-68 PSMA-11 PET/CT is useful for improving detection of tumor recurrence or progression, as opposed to treatment effects, in patients with gliomas.

NCT ID: NCT06444399 Not yet recruiting - Clinical trials for Pityriasis Rubra Pilaris

Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of Deucravacitinib (BMS-986165) in Pityriasis Rubra Pilaris as assessed by the change in Investigator Global Assessment (IGA), PASI- 50, 75, 90, DLQI, NRS itch, and Skindex-16 at week 24. To predict responses through the identification of unique biomarkers of PRP utilizing single-cell RNA sequencing.

NCT ID: NCT06444386 Completed - Clinical trials for Cardiac Resynchronization Therapy

ECGi of SyncAV With MultiPoint Pacing

Start date: September 29, 2021
Phase:
Study type: Observational

The objective of this clinical study was to evaluate the impact of Multipoint Pacing (MPP) and SyncAV programming on ventricular electrical activation time and activation sequence using noninvasive electrocardiographic imaging (ECGi) in patients receiving cardiac resynchronization therapy (CRT).

NCT ID: NCT06444360 Not yet recruiting - HIV Clinical Trials

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Young Gay/Bisexual Minority Men (IMPACT)

IMPACT
Start date: July 22, 2024
Phase: N/A
Study type: Interventional

The use of behavioral intervention to reduce stimulant use and concurrent HIV sexual transmission risk

NCT ID: NCT06444347 Not yet recruiting - Hiatal Hernia Clinical Trials

Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair

Start date: June 2024
Phase: N/A
Study type: Interventional

The aim of this study is to find out if using a certain kind of mesh can reduce the chances of hiatal hernias coming back after anti-reflux surgery. Participants undergoing antireflux surgery will be assigned to one of two groups, a group that has surgery with mesh, or a group that has surgery without mesh.

NCT ID: NCT06444282 Not yet recruiting - Emergencies Clinical Trials

Emergency Care Action Plans for Infants With Medical Complexity

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

An Emergency Care Action Plan (ECAP) is a tool intended to be helpful to providers when treating a child with complex medical needs during an emergency. Once created, ECAPs are added to the Electronic Health Record (EHR), shared with the child's caregiver(s), and kept up by all of those involved in a child's care. The goal of this study is to measure important health outcomes (ex. inpatient days, emergency department visits) in terms of the use of the ECAP for infants discharged from the Neonatal Intensive Care Unit (NICU). This study will also measure other real-time potential challenges related to the use of the ECAP including, but not limited to, if it is being used, if providers and caregivers want to use it, and if they keep using it over a long period of time.

NCT ID: NCT06444269 Not yet recruiting - Breast Cancer Clinical Trials

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

1. Efficacy of PULSAR preoperative radiation 2. Evaluate potential of microbubble CEUS as an alternative to operative SLNBx 3. Evaluate potential of OA to evaluate treatment response of pre-operative radiation on the tumor

NCT ID: NCT06444256 Not yet recruiting - Clinical trials for Stimulant Use Disorder

Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Start date: June 30, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.